{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:56:57Z","timestamp":1774364217786,"version":"3.50.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s40273-025-01572-2","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T03:16:54Z","timestamp":1767496614000},"page":"461-475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Developing and Calibrating a Colorectal Cancer Microsimulation Model for Northern Ireland"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1870-3818","authenticated-orcid":false,"given":"Olivia","family":"Adair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8918-7822","authenticated-orcid":false,"given":"Ethna","family":"McFerran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3930-8470","authenticated-orcid":false,"given":"Mark","family":"Lawler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6286-8062","authenticated-orcid":false,"given":"Luuk A.","family":"van Duuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8395-2415","authenticated-orcid":false,"given":"Felicity","family":"Lamrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,4]]},"reference":[{"issue":"3","key":"1572_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1572_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338\u201344.","journal-title":"Gut"},{"key":"1572_CR3","unstructured":"Northern Ireland Cancer Registry. Colorectal Cancer. 2025. Available from: https:\/\/www.qub.ac.uk\/research-centres\/nicr\/ [Accessed on: 2025 Feb 20]"},{"issue":"8","key":"1572_CR4","doi-asserted-by":"publisher","first-page":"836","DOI":"10.7326\/0003-4819-119-8-199310150-00010","volume":"119","author":"JH Bond","year":"1993","unstructured":"Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with nonfamilial colorectal polyps. Ann Intern Med. 1993;119(8):836\u201343.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1572_CR5","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.bpg.2007.09.004","volume":"21","author":"SJ Winawer","year":"2007","unstructured":"Winawer SJ. Colorectal cancer screening. Best Pract Res Clin Gastroenterol. 2007;21(6):1031\u201348.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"9","key":"1572_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM198809013190901","volume":"319","author":"B Vogelstein","year":"1988","unstructured":"Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319(9):525\u201332.","journal-title":"N Engl J Med"},{"key":"1572_CR7","unstructured":"Cancer Research UK. Bowel cancer screening. 2023. Available: https:\/\/www.cancerresearchuk.org\/about-cancer\/bowel-cancer\/getting-diagnosed\/screening. Accessed 25 Jan 2025."},{"key":"1572_CR8","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10620-015-3600-5","volume":"60","author":"AG Zauber","year":"2015","unstructured":"Zauber AG. The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig Dis Sci. 2015;60:681\u201391.","journal-title":"Dig Dis Sci"},{"issue":"54","key":"1572_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ctrv.2017.02.002","volume":"1","author":"NC Vermeer","year":"2017","unstructured":"Vermeer NC, Snijders HS, Holman FA, Liefers GJ, Bastiaannet E, van de Velde CJ, et al. Colorectal cancer screening: systematic review of screen-related morbidity and mortality. Cancer Treat Rev. 2017;1(54):87\u201398.","journal-title":"Cancer Treat Rev"},{"key":"1572_CR10","unstructured":"Gray AM, Clarke PM, Wolstenholme JL, Wordsworth S. Applied methods of cost-effectiveness analysis in healthcare. OUP Oxford; 2010."},{"key":"1572_CR11","doi-asserted-by":"crossref","unstructured":"Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oup Oxford; 2006.","DOI":"10.1093\/oso\/9780198526629.001.0001"},{"key":"1572_CR12","doi-asserted-by":"crossref","unstructured":"Adair O, Lamrock F, O\u2019Mahony JF, Lawler M, McFerran E. A comparison of international modelling methods to evaluate health economics of colorectal cancer screening: a systematic review. Value Health. 2023; 12(1):14.","DOI":"10.1186\/s13643-023-02173-w"},{"issue":"4","key":"1572_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2165\/00019053-199813040-00003","volume":"13","author":"A Briggs","year":"1998","unstructured":"Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics. 1998;13(4):397\u2013409.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"1572_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/0272989X10369005","volume":"31","author":"CM Rutter","year":"2011","unstructured":"Rutter CM, Zaslavsky AM, Feuer EJ. Dynamic microsimulation models for health outcomes: a review. Med Decis Making. 2011;31(1):10\u20138.","journal-title":"Med Decis Making"},{"key":"1572_CR15","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1136\/gutjnl-2015-309316","volume":"64","author":"F Van Hees","year":"2015","unstructured":"Van Hees F, Zauber AG, Van Veldhuizen H, Heijen MLA, Penning C, Koning HJde, et al. The value of models in informing resource allocation in colorectal cancer screening: the case of The Nethrelands. Gut. 2015;64:1985\u201397.","journal-title":"Gut"},{"key":"1572_CR16","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2021.5746","volume":"325","author":"AB Knudsen","year":"2021","unstructured":"Knudsen AB, Rutter CM, Peterse EF, Lietz AP, Seguin CI, Meester RG, et al. Colorectal cancer screening: an updated modelling study for the US Preventive Services Task Force. JAMA. 2021;325:1998\u20132011.","journal-title":"JAMA"},{"issue":"7","key":"1572_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40273-024-01364-0","volume":"42","author":"I Corro Ramos","year":"2024","unstructured":"Corro Ramos I, Feenstra T, Ghabri S, Al M. Evaluating the validation process: embracing complexity and transparency in health economic modelling. Pharmacoeconomics. 2024;42(7):715\u20139.","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"1572_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/0272989X221085569","volume":"42","author":"P Shewmaker","year":"2022","unstructured":"Shewmaker P, Chrysanthopoulou SA, Iskandar R, Lake D, Jutkowitz E. Microsimulation model calibration with approximate Bayesian computation in R: a tutorial. Med Decis Making. 2022;42(5):557\u201370.","journal-title":"Med Decis Making"},{"key":"1572_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2165\/11584600-000000000-00000","volume":"29","author":"T Vanni","year":"2011","unstructured":"Vanni T, Karnon J, Madan J, White RG, Edmunds WJ, Foss AM, et al. Calibrating models in economic evaluation: a seven-step approach. Pharmacoeconomics. 2011;29:35\u201349.","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"1572_CR20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1177\/0272989X10384738","volume":"31","author":"S Whyte","year":"2011","unstructured":"Whyte S, Walsh C, Chilcott J. Bayesian calibration of a natural history model with application to a population model for colorectal cancer. Med Decis Making. 2011;31(4):625\u201341.","journal-title":"Med Decis Making"},{"issue":"6","key":"1572_CR21","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1177\/0272989X211009161","volume":"41","author":"SA Chrysanthopoulou","year":"2021","unstructured":"Chrysanthopoulou SA, Rutter CM, Gatsonis CA. Bayesian versus empirical calibration of microsimulation models: a comparative analysis. Med Decis Making. 2021;41(6):714\u201326.","journal-title":"Med Decis Making"},{"issue":"1","key":"1572_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002803","volume":"9","author":"M Sunn\u00e5ker","year":"2013","unstructured":"Sunn\u00e5ker M, Busetto AG, Numminen E, Corander J, Foll M, Dessimoz C. Approximate bayesian computation. PLoS Comput Biol. 2013;9(1):e1002803.","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"1572_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s40273-017-0494-4","volume":"35","author":"NA Menzies","year":"2017","unstructured":"Menzies NA, Soeteman DI, Pandya A, Kim JJ. Bayesian methods for calibrating health policy models: a tutorial. Pharmacoeconomics. 2017;35(6):613\u201324.","journal-title":"Pharmacoeconomics"},{"key":"1572_CR24","unstructured":"R Core Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2025. Available: https:\/\/www.Rproject.org\/. Accessed 25 Apr 2025."},{"key":"1572_CR25","doi-asserted-by":"publisher","DOI":"10.1201\/9781003031819","volume-title":"R for health technology assessment","author":"G Baio","year":"2025","unstructured":"Baio G, Thom H, Pechlivanoglou P. R for health technology assessment. CRC Press; 2025."},{"key":"1572_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jval.2019.01.003","volume":"22","author":"D Incerti","year":"2019","unstructured":"Incerti D, Thom H, Baio G, Jansen JP. R you still using excel? The advantages of modern software tools for health technology assessment. Value Health. 2019;22:575\u20139.","journal-title":"Value Health"},{"key":"1572_CR27","unstructured":"Rockwell Automation. Discrete event modeling. modeling empowers you to optimize complex processes. 2024. Available: https:\/\/www.rockwellautomation.com\/en-gb\/products\/software\/arena-simulation\/discrete-event-modeling.html Accessed 11 Nov 2024."},{"key":"1572_CR28","doi-asserted-by":"publisher","DOI":"10.1201\/b19421","volume-title":"Discrete event simulation for health technology assessment","author":"JJ Caro","year":"2015","unstructured":"Caro JJ, M\u00f6ller J, Karnon J, Stahl J, Ishak J. Discrete event simulation for health technology assessment. CRC Press; 2015."},{"key":"1572_CR29","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1158\/1055-9965.EPI-15-0085","volume":"24","author":"HG Coleman","year":"2015","unstructured":"Coleman HG, Loughrey MB, Murray L, Johnston BT, Gavin AT, Shrubsole MJ, et al. Colorectal cancer risk following adenoma removal: a large prospective population-based cohort study. Cancer Epidemiol Biomarkers Prev. 2015;24:1373\u201380.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1572_CR30","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1053\/gast.2003.50044","volume":"124","author":"S Winawer","year":"2003","unstructured":"Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale\u2014update based on new evidence. Gastroenterology. 2003;124:544\u201360.","journal-title":"Gastroenterology"},{"key":"1572_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/9781118763971","volume-title":"Growth curve modeling: theory and applications","author":"MJ Panik","year":"2014","unstructured":"Panik MJ. Growth curve modeling: theory and applications. John Wiley & Sons; 2014."},{"key":"1572_CR32","unstructured":"CISNET Colorectal Working Group. MISCAN-Colon: Colorectal Cancer Model. https:\/\/cisnet.cancer.gov\/resources\/model-registry\/colorectal-models\/MISCAN-colon.html#\/. Accessed: 2025-07-23. 2025"},{"key":"1572_CR33","doi-asserted-by":"publisher","first-page":"238146832098497","DOI":"10.1177\/2381468320984974","volume":"6","author":"A Gini","year":"2021","unstructured":"Gini A, Buskermolen M, Senore C, Anttila A, Novak Mlakar D, Veerus P, et al. Development and validation of three regional microsimulation models for predicting colorectal cancer screening benefits in Europe. MDM Policy Pract. 2021;6:2381468320984974.","journal-title":"MDM Policy Pract"},{"key":"1572_CR34","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1177\/0272989X231184175","volume":"43","author":"V Vahdat","year":"2023","unstructured":"Vahdat V, Alagoz O, Chen JV, Saoud L, Borah BJ, Limburg PJ. Calibration and validation of the colorectal cancer and adenoma incidence and mortality (CRC-AIM) microsimulation model using deep neural networks. Med Decis Making. 2023;43:719\u201336.","journal-title":"Med Decis Making"},{"key":"1572_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00265-010-1029-6","volume":"65","author":"KP Burnham","year":"2011","unstructured":"Burnham KP, Anderson DR, Huyvaert KP. AIC model selection and multimodel inference in behavioral ecology: some background, observations, and comparisons. Behav Ecol Sociobiol. 2011;65:23\u201335.","journal-title":"Behav Ecol Sociobiol"},{"key":"1572_CR36","unstructured":"Northern Ireland Research and Statistics Agency. \u201c2021 census.\u201d 2021. Available: https:\/\/www.nisra.gov.uk\/statistics\/census\/2021-census Accessed 12 July 2024."},{"key":"1572_CR37","unstructured":"Northern Ireland Statistics and Research Agency (NISRA). 2022 Mid-Year population estimates for Northern Ireland. 2023. Available from: https:\/\/www.nisra.gov.uk\/publications\/2022-mid-year-population-estimates-northern-ireland [Accessed on: 19 Oct 2023]."},{"key":"1572_CR38","unstructured":"Office for National Statistics. National life tables: Northern Ireland. 2024. Available: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/lifeexpectancies\/datasets\/nationallifetablesnorthernirelandreferencetables. Accessed 31 Jan 2024."},{"key":"1572_CR39","unstructured":"Northern Ireland Cancer Registry. Colorectal Cancer. 2024. Available from: https:\/\/www.qub.ac.uk\/research-centres\/nicr\/CancerInformation\/official-statistics\/BySite\/Colorectalcancer\/ [Accessed on: 19 Aug 2024]."},{"key":"1572_CR40","unstructured":"CISNET Colorectal Working Group. CRC-SPIN: Colorectal Cancer Model. 2025. https:\/\/cisnet.cancer.gov\/resources\/model-registry\/colorectal-models\/CRC-SPIN.html#\/. [Accessed: 23 July 2025]."},{"key":"1572_CR41","volume-title":"Pathways to Cancer Diagnosis: Monitoring variation in the patient journey across Northern Ireland","author":"F Bannon","year":"2020","unstructured":"Bannon F, McKenna H, Donnelly C, Mayock M, Harbinson A, Mathieson S, et al. Pathways to Cancer Diagnosis: Monitoring variation in the patient journey across Northern Ireland. Queen\u2019s University, Belfast, Health and Social Care Business Services Organisation; 2020."},{"key":"1572_CR42","unstructured":"Public Health Agency. Bowel screening. 2024. Available: https:\/\/cancerscreening.hscni.net\/bowel-screening\/overview\/ Accessed 19 Aug 2024."},{"issue":"10","key":"1572_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017186","volume":"7","author":"J Murphy","year":"2017","unstructured":"Murphy J, Halloran S, Gray A. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England. BMJ Open. 2017;7(10):e017186.","journal-title":"BMJ Open"},{"issue":"2","key":"1572_CR44","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1148\/radiol.11102411","volume":"261","author":"DJ Vanness","year":"2011","unstructured":"Vanness DJ, Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, Gareen IF, Herman BA, et al. Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three Cancer Intervention and Surveillance Modeling Network microsimulations. Radiology. 2011;261(2):487\u201398.","journal-title":"Radiology"},{"key":"1572_CR45","unstructured":"British Society for Gastroenterology. BSG\/ACPGBI\/PHE postpolypectomy and post-colorectal cancer resection surveillance guidelines. 2020. Available from: https:\/\/www.bsg.org.uk\/clinical-resource\/list-of-recommendations [Accessed on: 12 Dec 2024]"},{"key":"1572_CR46","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/0272989X18792283","volume":"38","author":"F Alarid-Escudero","year":"2018","unstructured":"Alarid-Escudero F, MacLehose RF, Peralta Y, Kuntz KM, Enns EA. Nonidentifiability in model calibration and implications for medical decision making. Med Decis Making. 2018;38:810\u201321.","journal-title":"Med Decis Making"},{"key":"1572_CR47","unstructured":"Northern Ireland High Performance Computing. \u201cKelvin2.\u201d 2025. Available: https:\/\/www.ni-hpc.ac.uk\/Kelvin2\/ [Accessed: 7 March 2025]."},{"issue":"247","key":"1572_CR48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/01621459.1949.10483310","volume":"44","author":"N Metropolis","year":"1949","unstructured":"Metropolis N, Ulam S. The monte carlo method. J Am Stat Assoc. 1949;44(247):335\u201341.","journal-title":"J Am Stat Assoc"},{"key":"1572_CR49","doi-asserted-by":"crossref","unstructured":"Sisson SA and Fan Y. Likelihood-free markov chain monte carlo. arXiv preprint arXiv:1001.2058 2010","DOI":"10.1201\/b10905-13"},{"key":"1572_CR50","unstructured":"CISNET Colorectal Working Group. SimCRC: Colorectal Cancer Model. https:\/\/cisnet.cancer.gov\/resources\/model-registry\/colorectal-models\/SimCRC.html#\/. Accessed: 2025-07-23. 2025"},{"key":"1572_CR51","unstructured":"Thom H, Lamrock F, and Smith R. R for HTA. 2025. Available from: https:\/\/r-hta.org\/ [Accessed on: 2025 Jul 22]"},{"key":"1572_CR52","unstructured":"Pechlivanoglou P, Enns E, Alarid-Escudero F, Krijkamp E, Jalal H, Yang A, and Hunink M. Decision Analysis in R for Technologies in Health (DARTH). 2025. Available from: https:\/\/darthworkgroup.com\/ [Accessed on: 2025 Jul 22]"},{"key":"1572_CR53","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1177\/0272989X18754513","volume":"38","author":"EM Krijkamp","year":"2018","unstructured":"Krijkamp EM, Alarid-Escudero F, Enns EA, Jalal HJ, Hunink MM, Pechlivanoglou P. Microsimulation modeling for health decision sciences using R: a tutorial. Med Decis Making. 2018;38:400\u201322.","journal-title":"Med Decis Making"},{"key":"1572_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0272989X221103163","volume":"43","author":"F Alarid-Escudero","year":"2023","unstructured":"Alarid-Escudero F, Krijkamp E, Enns EA, Yang A, Hunink MM, Pechlivanoglou P, et al. An introductory tutorial on cohort state-transition models in R using a cost-effectiveness analysis example. Med Decis Making. 2023;43:3\u201320.","journal-title":"Med Decis Making"},{"key":"1572_CR55","doi-asserted-by":"crossref","unstructured":"Green N, Lamrock F, Naylor N, Williams J, Briggs A. Health economic evaluation using Markov models in R for microsoft excel users: a tutorial. PharmacoEconomics 2023;41(1):5\u201319","DOI":"10.1007\/s40273-022-01199-7"},{"key":"1572_CR56","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s40273-019-00837-x","volume":"37","author":"F Alarid-Escudero","year":"2019","unstructured":"Alarid-Escudero F, Krijkamp EM, Pechlivanoglou P, Jalal H, Kao SYZ, Yang A, et al. A need for change! A coding framework for improving transparency in decision modeling. Pharmacoeconomics. 2019;37:1329\u201339.","journal-title":"Pharmacoeconomics"},{"key":"1572_CR57","unstructured":"O\u2019Hagan A and Luce B. A primer on Bayesian statistics in health economics and outcomes research. Seattle, United States of America: MEDTAP International 2003"},{"key":"1572_CR58","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1198\/jasa.2009.ap07466","volume":"104","author":"CM Rutter","year":"2009","unstructured":"Rutter CM, Miglioretti DL, Savarino JE. Bayesian calibration of microsimulation models. J Am Stat Assoc. 2009;104:1338\u201350.","journal-title":"J Am Stat Assoc"},{"key":"1572_CR59","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1214\/19-AOAS1279","volume":"13","author":"CM Rutter","year":"2019","unstructured":"Rutter CM, Ozik J, DeYoreo M, Collier N. Microsimulation model calibration using incremental mixture approximate Bayesian computation. Ann Appl Stat. 2019;13:2189.","journal-title":"Ann Appl Stat"},{"key":"1572_CR60","doi-asserted-by":"crossref","unstructured":"Pineda-Antunez C, Seguin C, Duuren LA van, Knudsen AB, Davidi B, Lima P Nascimento de, Rutter C, Kuntz KM, Lansdorp-Vogelaar I, Collier N, et al. Emulator-based Bayesian calibration of the CISNET colorectal cancer models. Med Decision Making 2024; 44:543\u201353.","DOI":"10.1177\/0272989X241255618"},{"key":"1572_CR61","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/comjnl\/7.4.308","volume":"7","author":"JA Nelder","year":"1965","unstructured":"Nelder JA, Mead R. A simplex method for function minimization. Comput J. 1965;7:308\u201313.","journal-title":"Comput J"},{"key":"1572_CR62","unstructured":"Mandrik O, Thomas C, Strong M, and Whyte S. Calibration and validation of the Microsimulation Model in Cancer of the Bowel (MiMiC-Bowel), an individual patient simulation model for investigation of the cost-effectiveness of personalised screening and surveillance strategies. HEDS Discussion Paper Series 2021"},{"key":"1572_CR63","doi-asserted-by":"crossref","unstructured":"Sharp L, Tilson L, Whyte S, Ceilleachair AO, Walsh C, Usher C, Tappenden P, Chilcott J, Staines A, Barry M, and Comber H. Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland. BMC Health Services Res 2013; 13(105). Available from: http:\/\/www.biomedcentral.com\/1472-6963\/13\/105.","DOI":"10.1186\/1472-6963-13-105"},{"key":"1572_CR64","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1177\/0272989X11408730","volume":"31","author":"KM Kuntz","year":"2011","unstructured":"Kuntz KM, Lansdorp-Vogelaar I, Rutter CM, Knudsen AB, Van Ballegooijen M, Savarino JE, et al. A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression. Med Decis Making. 2011;31:530\u20139.","journal-title":"Med Decis Making"},{"issue":"11","key":"1572_CR65","doi-asserted-by":"publisher","first-page":"900","DOI":"10.7326\/0003-4819-128-11-199806010-00006","volume":"128","author":"H Ahsan","year":"1998","unstructured":"Ahsan H, Neugut AI, Garbowski GC, Jacobson JS, Forde KA, Treat MR, et al. Family history of colorectal adenomatous polyps and increased risk for colorectal cancer. Ann Intern Med. 1998;128(11):900\u20135.","journal-title":"Ann Intern Med"},{"issue":"17","key":"1572_CR66","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/cncr.30080","volume":"122","author":"JT Lowery","year":"2016","unstructured":"Lowery JT, Ahnen DJ, Schroy PC III, Hampel H, Baxter N, Boland CR, et al. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: a state-of-the-science review. Cancer. 2016;122(17):2633\u201345.","journal-title":"Cancer"},{"issue":"1","key":"1572_CR67","doi-asserted-by":"publisher","DOI":"10.1177\/23814683221145701","volume":"8","author":"CY Cheng","year":"2023","unstructured":"Cheng CY, Calderazzo S, Schramm C, Schlander M. Modeling the natural history and screening effects of colorectal cancer using both adenoma and serrated neoplasia pathways: the development, calibration, and validation of a discrete event simulation model. MDM Policy Pract. 2023;8(1):23814683221145701.","journal-title":"MDM Policy Pract"},{"issue":"4","key":"1572_CR68","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1053\/j.gastro.2015.11.046","volume":"150","author":"R Erichsen","year":"2016","unstructured":"Erichsen R, Baron JA, Hamilton-Dutoit SJ, Snover DC, Torlakovic EE, Pedersen L, et al. Increased risk of colorectal cancer development among patients with serrated polyps. Gastroenterology. 2016;150(4):895\u2013902.","journal-title":"Gastroenterology"},{"key":"1572_CR69","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/S0140-6736(17)30396-3","volume":"389","author":"W Atkin","year":"2017","unstructured":"Atkin W, Wooldrage K, Parkin DM, Kralj-Hans I, MacRae E, Shah U, et al. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK flexible sigmoidoscopy screening randomised controlled trial. Lancet. 2017;389:1299\u2013311.","journal-title":"Lancet"},{"key":"1572_CR70","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1055\/s-0032-1306895","volume":"44","author":"M Kaminski","year":"2012","unstructured":"Kaminski M, Bretthauer M, Zauber AG, Kuipers EJ, Adami HO, van Ballegooijen M, et al. The NordICC study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy. 2012;44:695\u2013702.","journal-title":"Endoscopy"},{"key":"1572_CR71","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2165\/11584610-000000000-00000","volume":"29","author":"J Karnon","year":"2011","unstructured":"Karnon J, Vanni T. Calibrating models in economic evaluation: a comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteria. Pharmacoeconomics. 2011;29:51\u201362.","journal-title":"Pharmacoeconomics"}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-025-01572-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40273-025-01572-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-025-01572-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:03:08Z","timestamp":1774360988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40273-025-01572-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,4]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1572"],"URL":"https:\/\/doi.org\/10.1007\/s40273-025-01572-2","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,4]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests. ML declares honoraria from Bayer, Carnall Farrar, EMD Serono, Novartis, Pfizer and Roche unrelated to this work. EMcF declares honoraria from Gilead Sciences unrelated to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Data may be available upon reasonable request from the corresponding author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Data are available on request from the corresponding author.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"OA undertook the role of lead author for this article, with FL as senior author. OA and FL developed the model structure. OA built the natural history and cost-effectiveness model in R. FL validated model code. All authors read, edited and approved the final version.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}